Automated visual inspection has been created to perform as an alternative to manual visual inspection. This type of inspection is used to lower the cost and speed up the inspection process; pushing more drugs into the market. In USP <1790> it explains that any inspection other than manual inspection has to be “equivalent or better…
Read more
Hospira Issues A Voluntary Nationwide Recall
On May 4th, 2021, Hospira—a Pfizer company, issued a voluntary nationwide recall to lot DN9185 for potential presence of visible particles. This drug product is a sterile water for injectables and is used to dilute or dissolve drugs for injection. Risks to patients are rare, but could potentially conclude anaphylaxis, fever, gastrointestinal disturbances, vein irritation,…
Read more
Testing Container Closures with Dye Ingress Method
The dye ingress test method is a routine test for container closures attached to parenteral drugs and large molecule drugs. Traditionally, this method uses ten test samples and three positive controls. During this testing, the test samples are place in a vacuum chamber and pressurized with dye. Three vials are punctured to allow dye to…
Read more
Testing Container Closures
During the manufacturing process of injectable drugs, all pieces and parts need to go through a visual inspection process. The container, closure, product and final product all need to have individual inspections. Container closure integrity is extremely important, especially when involved with parenteral drugs. Parenteral drugs have the highest risk packaging application concern for closure…
Read more